EMEA-000990-PIP02-10

Key facts

Active substance
  • Azelastine (hydrochloride)
  • fluticasone (propionate)
Therapeutic area
Pneumology-allergology
Decision number
P/82/2011
PIP number
EMEA-000990-PIP02-10
Pharmaceutical form(s)
  • Nasal spray
  • suspension
Condition(s) / indication(s)
  • Treatment of rhino-conjuctivitis
  • Treatment of allergic rhinitis
Route(s) of administration
Nasal use
Contact for public enquiries
MEDA Pharma GmbH & Co. KG
info@medapharma.de
Germany
Phone +49 617288801
Fax +49 61728881112
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Compliance procedure number
EMEA-C-000990-PIP02-10
Compliance opinion date
24/06/2011
Compliance outcome
positive

Decision

How useful was this page?

Add your rating